Trailer Wizards Joins TIP Group
30.12.2019 16:00:00 EET | Business Wire | Press release
TIP Trailer Services, a portfolio company of I Squared Capital and one of the leading trailer leasing, rental, maintenance and repair providers across Europe and Canada, today announces it has completed the acquisition of Trailer Wizards, a leading supplier of trailer rental and leasing services in Canada. This follows the announcement of 4 September 2019 on the signing of the agreement for the acquisition.
Following the acquisition, TIP will integrate Trailer Wizards with its existing Canadian business, Train Trailer Rentals. This puts TIP in a strong position for long-term growth as it further strengthens its position in the Canadian market. The acquisition diversifies both the geographical footprint across Canada with the expansion of operations to new provinces and the service segment with more specialized trailers.
“After the recent acquisition of PEMA in Europe, the acquisition of Trailer Wizards is another key milestone in the growth path of TIP,” said Bob Fast, President and CEO of TIP Trailer Services. “By joining the teams of Trailer Wizards and Train Trailer Rentals, we can provide the best in flexible commercial trailer fleet solutions and pursue growth opportunities for the combined businesses. We intend to invest to develop our longstanding customer relationships with world-class transport, logistics, and retail customers in Canada.”
TIP’s Canadian division will have a combined fleet of over 33,000 trailers, reefers, chassis and flatbed or drop-deck configurations. The combined business will employ over 500 people, including approximately 300 mechanics, throughout almost 30 locations in Canada from Prince Edward Island to British Columbia.
The management of the combined business is working together on an integration plan to allow a smooth transition. Unless communicated otherwise, existing contracts, services, terms and conditions and processes will remain in place at each of the businesses.
About TIP Trailer Services
Founded in 1968, TIP Trailer Services is an equipment service provider specializing in trailer leasing, rental, maintenance and repair, as well as other value-added services to transportation and logistics customers across Europe and Canada. The company has one of the largest and most diverse trailer rental and leasing fleets with over 120,000 units. Headquartered in Amsterdam, TIP has over 2,700 employees and services its customers from 120 locations in 18 countries across Europe and Canada. For more information, please visit: https://www.tipeurope.com
About Trailer Wizards
Founded in 1963, Trailer Wizards is Canada’s largest national commercial trailer rental, leasing, sales, service parts, and storage company. Today, Trailer Wizards has 21 locations spanning Canada coast-to-coast including 14 fully staffed customer care centers. For more information, please visit: https://trailerwizards.com
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20191230005029/en/
Contact information
TIP Europe
Media
Marc Aandeweg
Vice President Sales & Marketing
T +31 (0)20 504 – 1767
M +31 (0)613 114293
E marc.aandeweg@tipeurope.com
Investor Relations
Kapil Sharma
Treasury and Investor Relations Director
T +31 (0)20 504 1677
M +31 (0)621 105358
E kapil.sharma@tipeurope.com
Trailer Wizards
Saroj Motwani
Senior Marketing & Communications Specialist
+1 905 740 3925
saroj.motwani@trailerwizards.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
FDA Issues Modified Risk Tobacco Product Orders for 20 ZYN Nicotine Pouch Products30.6.2026 19:19:00 EEST | Press release
Philip Morris International Inc. (PMI) (NYSE: PM) today announced that the U.S. Food and Drug Administration (FDA) issued Modified Risk Tobacco Product (MRTP) orders for 20 variants of ZYN nicotine pouch products. These are the first MRTP orders granted for nicotine pouches, allowing PMI U.S. to market the following claim for the authorized ZYN products: “Using ZYN instead of cigarettes puts you at a lower risk of mouth cancer, heart disease, lung cancer, stroke, emphysema, and chronic bronchitis.” “FDA’s decision is an important moment for the more than 45 million legal-age nicotine consumers in America,” saidStacey Kennedy, PMI U.S. CEO. “Today’s news ensures these adultshave access to accurate, science-based information, including FDA-authorized evidence that switching from cigarettes to ZYN reduces the risk of smoking-related diseases like heart disease and lung cancer,” she added. “More broadly, it reinforces the agency’s science-based approach to evaluating products across the co
Caidya Announces Strategic Combination with Simbec-Orion Bridging Early Scientific Insight and Global Clinical Execution30.6.2026 18:00:00 EEST | Press release
Caidya today announced a strategic combination with Simbec-Orion designed to close the divide between early scientific insight and global clinical execution. The combination of Caidya and Simbec-Orion creates a differentiated specialty clinical CRO platform that enables programs to scale, maintaining focus, speed, and accountability. The strategic combination brings together complementary strengths to create a more complete development partner for innovative biopharma companies. With established operations across Europe, the Americas, APAC, and China, the combined organization provides meaningful expertise and execution capabilities in the regions that matter most. Simbec-Orion brings early-phase clinical pharmacology capabilities alongside deep therapeutic expertise for later stage complex oncology and rare disease trials, helping sponsors shape critical decisions early in the development lifecycle. Together, the organizations strengthen their ability to support complex, cross-border
Archer® Proves Purpose-Built AI Beats General-Purpose LLMs on Regulatory Change Management: 95% Verified Accuracy, 80x Faster, 92% Lower Cost30.6.2026 17:13:00 EEST | Press release
For enterprises deploying AI in compliance, a wrong date is a missed deadline. The more dangerous failure is a wrong answer the model returns with high confidence, one that flows silently into a compliance calendar and is only discovered after the window has passed. Archer® today released results showing purpose-built AI beats a general-purpose large language model (LLM) on regulatory work, and it’s not close. This head-to-head test compared Archer’s purpose-built, vertical-specific AI and proprietary data sets against a leading general-purpose LLM, on a core compliance task: determining the publication, effective and comment-close dates of regulatory documents across six jurisdictions. General-purpose models are a genuine breakthrough, and this is no referendum on their quality. The question Archer set out to answer is narrower and more practical: what it takes to make a specific, high-stakes determination reliable, fast and affordable at scale. A vertical, domain-focused process, gro
Altasciences Supports Key Development Milestone for Steel Therapeutics’ Lead Therapeutic Candidate, Fizurex™30.6.2026 17:08:00 EEST | Press release
Altasciences, a leading drug development organization, today announced a significant milestone in the development of Steel Therapeutics, Inc.’s pivotal toxicology study for its lead product candidate, Fizurex™, for the treatment of anal fissures. The successful completion of the study plays a significant role in the advancement of Fizurex™ toward first-in-human trials. The GLP-compliant study demonstrated a favorable safety profile, which has advanced Steel Therapeutics' plans to submit an Investigational New Drug (IND) application for Fizurex™ to the FDA in Q3 2026. Fizurex™, a patent-pending, single-use topical wipe, was designed to provide a standardized, accessible treatment option for a painful and often undertreated medical condition. The product builds on years of use through compounding pharmacy prescriptions and is now advancing toward clinical development and regulatory review. "We are proud to have supported Steel Therapeutics with the generation of the high-quality safety d
Interactive Brokers Expands Access to Korean Equities with Launch of Nextrade ATS30.6.2026 17:00:00 EEST | Press release
Interactive Brokers (Nasdaq: IBKR), an automated global broker, today announced the launch of select Korean equities through Nextrade, South Korea's first Alternative Trading System (ATS). The addition of Nextrade builds on Interactive Brokers' earlier launch of the Korea Exchange (KRX), through which it became the first major US-based broker to provide global investors with direct access to Korean equities. Clients trading on Nextrade benefit from significantly extended trading hours and access to additional liquidity. Interactive Brokers has enabled IB SmartRouting℠ across both the Korea Exchange (KRX) and Nextrade, automatically routing orders to the venue offering the best price. This helps clients achieve best execution while providing greater flexibility and more opportunities to participate in one of Asia's most dynamic equity markets. Korea's equity market ranks among the top global exchanges by market capitalization and is home to world-leading companies such as Samsung Electr
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom